Identification of surface molecules associated with physiologic activation of eosinophils: Application of whole-blood flow cytometry to eosinophils

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4851-4858

  Mawhorter, Steven D ^a   Stephany, David A ^a   Ottesen, Eric A ^a,b   Nutman, Thomas B ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FLOW CYTOMETRY; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; PRIORITY JOURNAL;

ANTHELMINTICS; ANTIGENS, SURFACE; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HELMINTHIASIS; HUMANS; IMMUNOPHENOTYPING; MALE;

EID: 0030009865     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hogg, N., and R. C. Landis. 1993. Adhesion molecules in cell interactions. Curr. Opin. Immunol 5:383.
2. Mackay, C. R., and B. A. Imhof. 1993. Cell adhesion in the immune system. Immunol. Today 14:99.
3. June, C. H. 1992. Analysis of lymphocyte activation and metabolism by flow cytometry. Curr. Opin. Immunol. 4:200.
4. Kuijpers, T. W., A. T. Tool, C. E. van der Schoot, L. A. Ginsel, J. J. Onderwater, D. Roos, and A. J. Verhoeven. 1991. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 78:1105.
5. Weller, P. F. 1994. Eosinophils: structure and functions. Curr. Opin. Immunol. 6:85.
6. Finkelman, F. D., E. J. Pearce, J. F. Urban, Jr., and A. Sher. 1991. Regulation and biological function of helminth-induced cytokine responses. Immunol. Today 12: A62.
7. Hansel, T. T., J. B. Braunstein, C. Walker, K. Blaser, P. L. Bruijnzeel, J. C. Virchow, Jr., and C. Virchow, Sr. 1991. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin. Exp. Immunol. 86:271.
8. Roberts, R. L., B. J. Ank, I. B. Salusky, and E. R. Stiehm. 1990. Purification and properties of peritoneal eosinophils from pediatric dialysis patients. J. Immunol. Methods 126:205.
9. Beninati, W., S. Derdak, P. F. Dixon, D. J. Grider, D. C. Strollo, R. E. Hensley, and D. R. Lucey. 1993. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J. Allergy Clin. Immunol. 92:442.
10. Winqvist, I., T. Olofsson, I. Olsson, A. M. Persson, and T. Hallberg. 1982. Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology 47:531.
11. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110.
12. Spry, C. J. F. 1988. Eosinophils: A Comprehensive Review, and Guide to the Scientific and Medical Literature. Oxford University Press, New York.
13. Seminario, M. C., and G. J. Gleich. 1994. The role of eosinophils in the pathogenesis of asthma. Curr. Opin. Immunol. 6:860.
14. Thorne, K. J., and G. Mazza. 1991. Eosinophilia, activated eosinophils and human schistosomiasis. J. Cell Sci. 98:265.
15. Hansel, T. T., I. J. deVries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105.
16. Ide, M., D. Weiler, H. Kita, and G. J. Gleich. 1994. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J. Immunol. Methods 168: 187.
17. Blom, M., A. T. Tool, F. P. Mul, E. F. Knol, D. Roos, and A. J. Verhoeven. 1995. Eosinophils isolated with two different methods show different characteristics of activation. J. Immunol. Methods 178:183.
18. Kipps, T. J., G. Meisenholder, and B. A. Robbins. 1992. New developments in flow cytometric analyses of lymphocyte markers. Clin. Lab. Med. 12:237.
19. Loken, M. R., J. M. Brosnan, B. A. Bach, and K. A. Ault. 1990. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453.
20. Terstappen, L. W., H. Meiners, and M. R. Loken. 1989. A rapid sample preparation technique for flow cytometric analysis of immunofluorescence allowing absolute enumeration of cell subpopulations. J. Immunol. Methods 123:103.
21. Prin, L., J. Plumas, V. Gruart, S. Loiseau, D. Aldebert, J. C. Ameisen, A. Vermersch, P. Fenaux, O. Bletry, and M. Capron. 1991. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 78:2626.
22. Wardlaw, A. J., G. M. Walsh, and F. A. Symon. 1994. Mechanisms of eosinophil and basophil migration. Allergy 49:797.
23. Gaga, M., A. J. Frew, V. A. Varney, and A. B. Kay. 1991. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J. Immunol. 147:816.
24. Pinkston, P., V. K. Vijayan, T. B. Nutman, W. N. Rom, K. M. O'Donnell, M. J. Cornelius, V. Kumaraswami, V. J. Ferrans, T. Takemura, G. Yenokidan, K. V. Thiruvengadam, S. P. Tripathy, E. A. Ottesen, and R. G. Crystal. 1987. Acute tropical pulmonary eosinophilia: characterization of the lower respiratory tract inflammation and its response to therapy. J. Clin. Invest. 80:216.
25. Sedgwick, J. B., W. J. Calhoun, R. F. Vrtis, M. E. Bates, P. K. McAllister, and W. W. Busse. 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:3710.
26. Mengelers, H. J., T. Maikoe, L. Brinkman, B. Hooibrink, J. W. Lammers, and L. Koenderman. 1994. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am. J. Respir. Crit. Care Med. 149:345.
27. Mengelers, H. J., T. Maikoe, B. Hooibrink, T. W. Kuypers, J. Kreukniet, J. W. Lammers, and L. Koenderman. 1993. Down modulation of L-selectin expression on eosinophils recovered from bronchoalveolar lavage fluid after allergen provocation. Clin. Exp. Allergy 23:196.
28. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
29. Walker, C., J. C. Virchow, Jr., P. L. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146:1829.
30. Her, E., J. Frazer, K. F. Austen, and W. F. Owen, Jr. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin. Invest. 88:1982.
31. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85.
32. Valent, P. 1994. The phenotype of human eosinophils, basophils, and mast cells. J. Allergy Clin. Immunol. 94:1177.
33. Nakamura, S., S. S. Sung, J. M. Bjorndahl, and S. M. Fu. 1989. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J. Exp. Med. 169:677.
34. Kuijpers, T. W., M. Hoogerwerf, L. J. van der Laan, G. Nagel, C. E. van der Schoot, F. Grunert, and D. Roos. 1992. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J. Cell Biol. 118:457.
35. Hartnell, A., D. S. Robinson, A. B. Kay, and A. J. Wardlaw. 1993. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80:281.
36. Czech, W., J. Krutmann, A. Budnik, E. Schopf, and A. Kapp. 1993. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J. Invest. Dermatol. 100:417.
37. Nishikawa, K., T. Morii, H. Ako, K. Hamada, S. Saito, and N. Narita. 1992. In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. J. Allergy Clin. Immunol. 90:169.
38. Testi, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479.
39. Testi, R., F. Pulcinelli, L. Frati, P. P. Gazzaniga, and A. Santoni. 1990. CD69 is expressed on platelets and mediates platelet activation and aggregation. J. Exp. Med 172:701.
40. Moretta, A.. A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor a/β. J. Exp. Med. 174:1393.
41. Bordessoule, D., M. Jones, K. C. Gatter, and D. Y. Mason. 1993. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br. J. Haematol. 83:370.
42. Bochner, B. S., F. W. Luscinskas, M. A. Gimbrone, Jr., W. Newman, S. A. Sterbinsky, C. P. Derse-Anthony, D. Klunk, and R. P. Schleimer. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173:1553.
43. Schleimer, R. P., and B. S. Bochner. 1991. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo [letter]. J. Immunol. 147:380.
44. Conrad, D. H., C. M. Squire, W. C. Bartlett, and S. E. Dierks. 1991. Fc epsilon receptors. Curr. Opin. Immunol. 3:859.
45. Capron, M., M. J. Truong, D. Aldebert, V. Gruart, M. Suemura, G. Delespesse, B. Tourvieille, and A. Capron. 1992. Eosinophil IgE receptor and CD23. Immunol. Res. 11:252.
46. Delespesse, G., U. Suter, D. Mossalayi, B. Bettler, M. Sarfati, H. Hofstetter, E. Kilcherr, P. Debre, and A. Dalloul. 1991. Expression, structure, and function of the CD23 antigen. Adv. Immunol. 49:149.
47. Wright, M. D., and M. G. Tomlinson. 1994. The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15:588.
48. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
49. Oren, R., S. Takahashi, C. Doss, R. Levy, and S. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10:4007.
50. Takahashi, S., C. Doss, S. Levy, and R. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J. Immunol. 145:2207.
51. Rothenberg, M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen, Jr. 1989. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311.
52. Mawhorter, S. D., E. Pearlman, J. W. Kazura, and W. H. Boom. 1993. Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi. Infect. Immun. 61:5410.